Howard Young, Ph.D., is Deputy Chief of the Laboratory of Experimental Immunology in the Cancer and Inflammation Program, as well as Principal Investigator and Head of the Cellular and Molecular Immunology Section at the NCI Center for Cancer Research. Dr. Young has expertise in the regulation and characterization of cytokine gene expression with a special emphasis on interferons. The Young laboratory has as its major focus how disruption of the control of interferon-γ (IFN-γ) gene expression during development and maturation of the cellular immune system impacts the host inflammatory response and the development of autoimmune disease and cancer. In addition, the laboratory is investigating a new cancer vaccine strategy utilizing tumor antigens engineered to adhere to the surface of probiotic microorganisms as a strategy to present these antigens to the gut and lung mucosal interfaces.
Posts By This Author
This page was last updated on Thursday, January 20, 2022